The role of hormonal therapy in prostate brachytherapy-Reference-Cited by-同舟云学术

The role of hormonal therapy in prostate brachytherapy

Published:2003-01 Issue:1 Volume:2 Page:2-4
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Merrick Gregory S

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference17 articles.

1. Palladium-103 brachytherapy for prostate carcinoma;Blasko;Int J Radiat Oncol Biol Phys,2000

2. Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma;Dattoli;Int J Radiat Oncol Biol Phys,1999

3. Biochemical outcome for hormone naı̈ve patients with high risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation;Merrick;Cancer J Sci Am,2002

4. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Oncology Group Protocol 85–31;Pilepich;J Clin Oncol,1997

5. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer;Brachytherapy;2017-03

2. Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence;Radiation Oncology;2012-03-26

3. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer;Brachytherapy;2011-09

4. Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy;Journal of Oncology;2010

5. Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy;Urology;2006-07